{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:25:56Z","timestamp":1793827556927,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.hoc.2021.12.004","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:35:32Z","timestamp":1646958932000},"page":"381-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Adult Evans' Syndrome"],"prefix":"10.1016","volume":"36","author":[{"given":"Marc","family":"Michel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2021.12.004_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archinte.1951.03810010058005","article-title":"Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology","volume":"87","author":"Evans","year":"1951","journal-title":"AMA Arch Intern Med"},{"issue":"24","key":"10.1016\/j.hoc.2021.12.004_bib2","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1182\/bloodadvances.2021005610","article-title":"Evans syndrome in adults: an observational multicentre study","volume":"5","author":"Fattizzo","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.hoc.2021.12.004_bib3","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2009-04-215368","article-title":"The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases","volume":"114","author":"Michel","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2021.12.004_bib4","first-page":"3851","article-title":"Evans' syndrome: from diagnosis to treatment","volume":"9","author":"Audia","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.hoc.2021.12.004_bib5","doi-asserted-by":"crossref","first-page":"16648","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the first international consensus meeting","volume":"41","author":"Jager","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.hoc.2021.12.004_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","article-title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2021.12.004_bib7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/ajh.25574","article-title":"Evans syndrome in adults - incidence, prevalence, and survival in a nationwide cohort","volume":"94","author":"Hansen","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2021.12.004_bib8","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1182\/blood-2014-06-583021","article-title":"Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients","volume":"124","author":"Barcellini","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2021.12.004_bib9","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.hoc.2021.12.004_bib10","doi-asserted-by":"crossref","first-page":"E150","DOI":"10.1002\/ajh.23767","article-title":"Characteristics and outcome of warm autoimmune hemolytic anemia in adults: new insights based on a single-center experience with 60 patients","volume":"89","author":"Roumier","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2021.12.004_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ajh.24665","article-title":"Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre","volume":"92","author":"Grall","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2021.12.004_bib12","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","article-title":"French reference center for thrombotic microangiopathies. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.hoc.2021.12.004_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2009.11.022","article-title":"Evans' syndrome in pregnancy: a systematic literature review and two new cases","volume":"149","author":"Lefkou","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.hoc.2021.12.004_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.05.007","article-title":"The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: a comprehensive review","volume":"92","author":"Cervera","year":"2018","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.hoc.2021.12.004_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/rheumatology\/keq395","article-title":"Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13","volume":"50","author":"Lansigan","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.hoc.2021.12.004_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2257.2006.00755.x","article-title":"Current hematological findings in cobalamin deficiency. A study of 201 consecutive patients with documented cobalamin deficiency","volume":"28","author":"Andres","year":"2006","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.hoc.2021.12.004_bib17","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"124","author":"Brodsky","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2021.12.004_bib18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.autrev.2014.01.001","article-title":"Diagnostic criteria for autoimmune neutropenia","volume":"13","author":"Youinou","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.hoc.2021.12.004_bib19","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2020.271106","article-title":"Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden","author":"Pincez","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.hoc.2021.12.004_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.hoc.2021.12.004_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset Evans syndrome: heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.hoc.2021.12.004_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10875-017-0456-9","article-title":"Autoimmune cytopenias and associated conditions in CVID: a report from the USIDNET registry","volume":"38","author":"Feuille","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.hoc.2021.12.004_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrrheum.2017.198","article-title":"Autoimmunity and primary immunodeficiency: two sides of the same coin?","volume":"14","author":"Schmidt","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.hoc.2021.12.004_bib24","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A\u00a0survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2021.12.004_bib25","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/s41467-020-18925-4","article-title":"Early-onset autoimmunity associated with SOCS1 haploinsufficiency","volume":"11","author":"Hadjadj","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.hoc.2021.12.004_bib26","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3389\/fonc.2019.01435","article-title":"Autoimmune cytopenias in chronic lymphocytic leukemia: focus on molecular aspects","volume":"9","author":"Fattizzo","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.hoc.2021.12.004_bib27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00277-016-2642-x","article-title":"Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome","volume":"95","author":"Carli","year":"2016","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.hoc.2021.12.004_bib28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/10428190701385173","article-title":"Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas","volume":"48","author":"Hauswirth","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.hoc.2021.12.004_bib29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ajh.5555","article-title":"Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome)","volume":"69","author":"Motta","year":"2002","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2021.12.004_bib30","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1002\/jmv.26906","article-title":"Evans syndrome and immune thrombocytopenia in two patients with COVID-19","volume":"93","author":"Georgy","year":"2021","journal-title":"J\u00a0Med Virol"},{"issue":"1","key":"10.1016\/j.hoc.2021.12.004_bib31","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2352-3026(18)30175-3","article-title":"Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study","volume":"6","author":"Delanoy","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.hoc.2021.12.004_bib32","doi-asserted-by":"crossref","first-page":"e3279","DOI":"10.1097\/MD.0000000000003279","article-title":"Clinical features of systemic lupus erythematosus patients complicated with Evans syndrome: a case-control, single center study","volume":"95","author":"Zhang","year":"2016","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.hoc.2021.12.004_bib33","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2352-3026(16)30109-0","article-title":"High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis","volume":"3","author":"Mithoowani","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.hoc.2021.12.004_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ajh.2830440404","article-title":"Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients","volume":"44","author":"Flores","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2021.12.004_bib35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00062752-200311000-00006","article-title":"Red blood cell transfusion in autoimmune hemolytic anemia","volume":"10","author":"Buetens","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.hoc.2021.12.004_bib36","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2012-09-455691","article-title":"Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia","volume":"121","author":"Gudbrandsdottir","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2021.12.004_bib37","article-title":"A\u00a0randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)","author":"Michel","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2021.12.004_bib38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/bjh.12541","article-title":"A\u00a0phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia","volume":"163","author":"Birgens","year":"2013","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.hoc.2021.12.004_bib39","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3324\/haematol.11540","article-title":"Rituximab therapy for childhood Evans syndrome","volume":"92","author":"Bader-Meunier","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.hoc.2021.12.004_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ejh.13336","article-title":"Long-term remission rates after splenectomy in adults with Evans syndrome compared to immune thrombocytopenia: a single-center retrospective study","volume":"104","author":"Sulpizio","year":"2020","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2021.12.004_bib41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/bjh.16009","article-title":"Bortezomib and dexamethasone, an original approach for treating multi-refractory warm autoimmune haemolytic anaemia","volume":"187","author":"Fadlallah","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2021.12.004_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211046428","article-title":"Bortezomib in autoimmune hemolytic anemia and beyond","volume":"12","author":"Pasquale","year":"2021","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.hoc.2021.12.004_bib43","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2021.279232","article-title":"Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia","author":"Crickx","year":"2021","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.hoc.2021.12.004_bib44","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/bjh.16959","article-title":"Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia","volume":"190","author":"Boccia","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2021.12.004_bib45","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ajh.24999","article-title":"Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: a multicenter retrospective cohort study of 71 adults","volume":"93","author":"Serris","year":"2018","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.hoc.2021.12.004_bib46","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2141.2011.08880.x","article-title":"Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients","volume":"155","author":"Gobert","year":"2011","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.hoc.2021.12.004_bib47","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/rheumatology\/key119","article-title":"Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists","volume":"57","author":"Guitton","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.hoc.2021.12.004_bib48","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/leu.2010.278","article-title":"Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia","volume":"25","author":"Rossignol","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2021.12.004_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","article-title":"Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: results of a prospective multi-institutional trial","volume":"127","author":"Bride","year":"2016","journal-title":"Blood"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858821001672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858821001672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:17:17Z","timestamp":1760185037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858821001672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0889858821001672"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2021.12.004","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult Evans' Syndrome","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2021.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}